• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

PFE:US

32.4500 USD 0.3600 1.10%

As of 20:04:06 ET on 01/23/2015.

Snapshot for Pfizer Inc (PFE)

Open: 32.8700 Day's Range: 32.4300 - 32.9000 Volume: 25,975,881
Previous Close: 32.8100 52wk Range: 27.5100 - 33.5000 1-Yr Rtn: +11.67%

Stock Chart for PFE

No chart data available.
  • PFE:US 32.4500
  • 1D
  • 1M
  • 1Y
32.8100
Interactive PFE Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PFE

Current P/E Ratio (ttm) 17.4561
Estimated P/E(12/2014) 14.4094
Relative P/E vs. SPX 0.9584
Earnings Per Share (USD) (ttm) 1.8590
Est. EPS (USD) (12/2014) 2.2520
Est. PEG Ratio 6.2650
Market Cap (M USD) 204,456.33
Shares Outstanding (M) 6,300.66
30 Day Average Volume 26,098,314
Price/Book (mrq) 2.6226
Price/Sale (ttm) 4.1391
Dividend Indicated Gross Yield 3.45%
Cash Dividend (USD) 0.2800
Dividend Ex-Date 02/04/2015
5 Year Dividend Growth 5.39%
Next Earnings Announcement 01/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PFE

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PFE

Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.

Ian C ReadChairman/CEOGeno J GermanoChief Innovation Officer
Albert BourlaPres:Vaccines & OncologyMikael DolstenPres:Worldwide Research & Dev
More Company Profile & Key Executives for PFE

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil